# Human Menopausal Gonadotropin Research in Infertility Assessing Cumulative Live Birth With Frozen Embryo Transfer.

> **NCT07216742** · PHASE3 · RECRUITING · sponsor: **Granata Bio Corporation** · enrollment: 659 (estimated)

## Conditions studied

- Infertility (IVF Patients)

## Interventions

- **DRUG:** hMG subcutaneous injection
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07216742
- **Lead sponsor:** Granata Bio Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-01
- **Primary completion:** 2028-11
- **Final completion:** 2028-11
- **Target enrollment:** 659 (ESTIMATED)
- **Last updated:** 2026-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07216742

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07216742, "Human Menopausal Gonadotropin Research in Infertility Assessing Cumulative Live Birth With Frozen Embryo Transfer.". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT07216742. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*